DABRAFENIB
dabrafenib 50 mg capsule, 120
DABRAFENIB (14755N)
14755N
Manner of administration:Oral
Restriction
Indication: Paediatric high grade glioma
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 240 | # of repeats: 3 | DPMQ: $9,489.92 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Tafinlar | |||||
